Arcturus Therapeutics
ARCT
ARCT
135 hedge funds and large institutions have $865M invested in Arcturus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 127 → 135 (+8)
2.24% more ownership
Funds ownership: 74.68% → 76.92% (+2.2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
135
Holding in Top 10
1
Calls
$46.9M
Puts
$37.1M
Top Buyers
1 | +$90.1M | |
2 | +$63.5M | |
3 | +$31.2M | |
4 |
O
OrbiMed
New York
|
+$28.7M |
5 |
BlackRock
New York
|
+$26.9M |
Top Sellers
1 | -$68.4M | |
2 | -$30M | |
3 | -$23.8M | |
4 |
Janus Henderson Group
London,
United Kingdom
|
-$20.7M |
5 |
EARNEST Partners
Atlanta,
Georgia
|
-$13.2M |